Metabolic labeling in middle-down proteomics allows for investigation of the dynamics of the histone code-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolic labeling in middle-down proteomics allows for investigation of the dynamics of the histone code

Published:2017-07-06 Issue:1 Volume:10 Page:
ISSN:1756-8935
Container-title:Epigenetics & Chromatin
language:en
Short-container-title:Epigenetics & Chromatin

Author:

Sidoli Simone,Lu Congcong,Coradin Mariel,Wang Xiaoshi,Karch Kelly R.,Ruminowicz Chrystian,Garcia Benjamin A.

Funder

National Institutes of Health

U.S. Department of Defense

Leukemia and Lymphoma Society

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13072-017-0139-z.pdf

Reference43 articles.

1. Xu D, Bai J, Duan Q, Costa M, Dai W. Covalent modifications of histones during mitosis and meiosis. Cell Cycle. 2009;8:3688–94.

2. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705.

3. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–80.

4. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol. 2007;14:1025–40.

5. Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol. 2003;15:172–83.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EXOSC4 is recruited by histone H3 co-modified with K9me3 and acetylations to surveil non-coding transcription;2024-08-05

2. Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation;Nature Communications;2024-06-17

3. Enrichment of histone tail methylated lysine residues via cavitand-decorated magnetic nanoparticles for ultra-sensitive proteomics;Chemical Science;2024

4. Streamlined quantitative analysis of histone modification abundance at nucleosome-scale resolution with siQ-ChIP version 2.0;Scientific Reports;2023-05-09

5. Biotransformation of Trastuzumab and Pertuzumab in Breast Cancer Patients Assessed by Affinity Enrichment and Ion-Exchange Chromatography;Drug Metabolism and Disposition;2022-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3